Post-earnings recap
Reported
Wed, May 10, 2017
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
CorMedix Inc. reported a loss of $0.19 per share for the first quarter of 2017. Despite the loss, the stock rose by 1.49%, indicating that investors may have had positive expectations or reactions to other aspects of the company. However, without additional context from management commentary or guidance, the reasons for the stock's increase remain unclear.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.19 | N/A | — |
| Revenue | — | N/A | — |
No transcript is on record, and the analysis is based on numerical results only.